Category | Details | N | % within category | % of included studies |
---|---|---|---|---|
Year of publication | 2015 | 14 | 14.6 | |
2016 | 21 | 21.9 | ||
2017 | 8 | 8.3 | ||
2018 | 19 | 19.8 | ||
2019 | 4 | 4.2 | ||
2020 | 2 | 2.1 | ||
2021 | 23 | 24.0 | ||
2022 | 5 | 5.2 | ||
Country | The Netherlands | 11 | 11.3 | 11.5 |
United States | 11 | 11.3 | 11.5 | |
United Kingdom | 10 | 10.3 | 10.4 | |
Australia | 8 | 8.3 | 8.3 | |
Korea | 6 | 6.2 | 6.3 | |
Spain | 6 | 6.2 | 6.3 | |
China | 6 | 6.2 | 6.3 | |
Norway | 5 | 5.2 | 5.2 | |
Japan | 4 | 4.1 | 4.2 | |
Taiwan, China | 4 | 4.1 | 4.2 | |
Canada | 3 | 3.1 | 3.1 | |
Less than 3 studiesa | 23 | 23.7 | 24.0 | |
Total countries reported | 97 | 100 | 101.0 | |
Study design | Intervention study | 80 | 83.3 | |
Observational Study | 12 | 12.5 | ||
Qualitative study | 4 | 4.2 | ||
Study codesign | Yesb | 12 | 12.5 | |
No or not reported | 84 | 87.5 | ||
Setting | Rural/Semi-rural | 18 | 18 | 18.8 |
Urban | 19 | 19 | 19.8 | |
Not reported | 63 | 63 | 65.6 | |
Total settings reported | 100 | |||
Most used age-related inclusion criteria | Older than 65 | 29 | 30.2 | |
Limitation by age | 6 | 6.2 | ||
Older than 18 | 17 | 17.7 | ||
Another criterion | 22 | 22.9 | ||
Not reported | 22 | 22.9 | ||
Participants’ sex predominance | Female predominance | 54 | 56.3 | |
Balanced | 27 | 28.1 | ||
Male predominance | 7 | 7.3 | ||
Not reported | 8 | 8.3 | ||
Target population | People with a decline in functioning/functional abilityc | 50 | 52.1 | |
People with a single health condition | 39 | 40.6 | ||
People with more than two health conditions | 7 | 7.3 | ||
Health condition area | Neurological | 12 | 30 | 12.5 |
Cardiovascular | 8 | 20 | 8.3 | |
Respiratory | 8 | 20 | 8.3 | |
Metabolic | 4 | 10 | 4.2 | |
Musculoskeletal | 3 | 7.5 | 3.1 | |
Pain | 2 | 5 | 2.1 | |
Autoimmune disease | 1 | 2.5 | 1.0 | |
Cancer | 1 | 2.5 | 1.0 | |
Communicable diseases | 1 | 2.5 | 1.0 | |
Number of health conditions reported | 40 | 100 | 41.7 | |
Health condition | Stroke | 9 | 22.5 | 9.4 |
COPD | 8 | 20 | 8.3 | |
Cardiovascular disease not specified | 3 | 7.5 | 3.1 | |
Diabetes | 3 | 7.5 | 3.1 | |
Heart failure | 3 | 7.5 | 3.1 | |
Less than 3 studiesd | 14 | 35 | 14.6 | |
Number of health conditions reported | 40 | 100 | 41.7 | |
Distribution of participant’s mean age | N | mean | SD | |
Quantile 1 | 21 | 57.8 | 3.7 | |
Quantile 2 | 17 | 67.7 | 2.4 | |
Quantile 3 | 31 | 74.9 | 2.3 | |
Quantile 4 | 21 | 81.8 | 1.8 |